Abstract:Human milk oligosaccharides (HMO) are the third most significant solid component in human milk, working in conjunction with other bioactive components. Numerous factors, including secretor status, race, geography, climate, season, maternal nutrition and weight, gestational age, and delivery method, significantly affect the individual HMO levels and distribution among mothers. In addition to strengthening the epithelial barrier, producing immunomodulatory metabolites, and promoting a gut microbiota rich in Bifidobacterium, HMO also help to enhance the gastrointestinal barrier. HMO perform a range of physiological roles, such as possible immune system support, brain growth, and cognitive function. HMO supplementation to infant formula is safe and supports the newborn's healthy growth, with benefits for infection prevention and the makeup of the microbiota. Through a thorough and methodical evaluation of relevant literature, this study investigated the complex interactions between gut microbiota, the immune system, and HMO in neonates. A sizable corpus of recently released original research publications and thorough review papers were examined in the review. SCOPUS, PubMed, and Google Scholar were reliable and strong sources of information. In addition to these, a few more trustworthy sources were consulted. By reading this article, readers will have a clear understanding of how HMO play a crucial role in influencing the dynamics of the gut microbiota and supporting the development of the immune system in newborns. The knowledge gained from these exchanges may help direct measures meant to improve the health of newborns. However, further investigation is necessary to identify certain underlying processes and possible treatment paths. It is unknown if HMO provide an extra clinical advantage over non-human oligosaccharides due to a lack of research comparing the effects of the two. Better study of the variables controlling HMO composition and their functions will assist to comprehend their short- and long-term advantages for Immunity and Healthy Digestive System in Newborn Infants Throughout Life.

Gastrointestinal barrier function, immunity, and neurocognition: The role of human milk oligosaccharide (hMO) supplementation in infant formula

Functional effects of human milk oligosaccharides (HMOs)

The Science of Human Milk Oligosaccharides (HMO) for Developing Immunity and Healthy Digestive System in Newborn Infants Throughout Life

Human Milk Oligosaccharides and Immune System Development

Human milk oligosaccharides and infant gut microbiota: Molecular structures, utilization strategies and immune function

Human Milk Oligosaccharides: Potential Upshot on Health at Early Life Stage Development

Human Milk Oligosaccharides and Their Pivotal Role in Gut-Brain Axis Modulation and Neurologic Development: A Narrative Review to Decipher the Multifaceted Interplay

Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula

Beneficial effects of human milk oligosaccharides on gut microbiota

How Far is It from Infant Formula to Human Milk? A Look at the Human Milk Oligosaccharides

Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro

Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiota

Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents

Current Perspective of Sialylated Milk Oligosaccharides in Mammalian Milk: Implications for Brain and Gut Health of Newborns

Relationship Between Oligosaccharides and Glycoconjugates Content in Human Milk and the Development of the Gut Barrier

Human Milk Oligosaccharides Combine with Bifidobacterium Longum to Form the “golden Shield” of the Infant Intestine: Metabolic Strategies, Health Effects, and Mechanisms of Action

Human Milk Oligosaccharides: A Critical Review on Structure, Preparation, Their Potential As a Food Bioactive Component, and Future Perspectives.

More than nutrition: Therapeutic potential and mechanism of human milk oligosaccharides against necrotizing enterocolitis

Potential anti-inflammatory and anti-infectious effects of human milk oligosaccharides

Gut microbiota: A key role for human milk oligosaccharides in regulating host health early in life

Human milk oligosaccharides differentially support gut barrier integrity and enhance Th1 and Th17 cell effector responses in vitro